Thank you, Doctor Klover! I think you're right, we can make ourselves happier with small gestures. That gives us agency, and that makes us feel even better. Carpe diem!
Really thoughtful perspective. Perhaps happiness is less something we find and more something we grow through curiosity, gratitude, relationships, and the small daily choices that shape how we experience life. Thanks for sharing this insightful piece.
Interesting observation about the long delay, and then metagenomics finally making psychobiotics specific enough to discuss at the strain level. If I read you correctly, “probiotic” is almost too broad to mean much biologically, since identity, context, and microbial neighbors seem to determine the effect. Is the next step strain-by-host matching rather than better universal blends?
Strain-by-host matching is the obvious next step, but it imports a problem psychiatry already knows well: responder heterogeneity. Match a strain to a host and you still face diet, transit time, and the resident community deciding whether the newcomer even colonizes. The harder question is whether "strain that produces GABA in vitro" survives contact with a gut that already has its own GABA economy. Personalized may just mean we stop pretending the average patient exists.
Thank you, Doctor Klover! I think you're right, we can make ourselves happier with small gestures. That gives us agency, and that makes us feel even better. Carpe diem!
Really thoughtful perspective. Perhaps happiness is less something we find and more something we grow through curiosity, gratitude, relationships, and the small daily choices that shape how we experience life. Thanks for sharing this insightful piece.
Well said 🌸🌱
Interesting observation about the long delay, and then metagenomics finally making psychobiotics specific enough to discuss at the strain level. If I read you correctly, “probiotic” is almost too broad to mean much biologically, since identity, context, and microbial neighbors seem to determine the effect. Is the next step strain-by-host matching rather than better universal blends?
Strain-by-host matching is the obvious next step, but it imports a problem psychiatry already knows well: responder heterogeneity. Match a strain to a host and you still face diet, transit time, and the resident community deciding whether the newcomer even colonizes. The harder question is whether "strain that produces GABA in vitro" survives contact with a gut that already has its own GABA economy. Personalized may just mean we stop pretending the average patient exists.
Right. Strain matters, but the ecosystem decides whether the signal becomes biology.
A nice reminder that identity matters..great read, thank you
Fascinating area, thanks for the overview.